149 related articles for article (PubMed ID: 27564450)
1. Material properties of bone in the femoral head treated with ibandronate and BMP-2 following ischemic osteonecrosis.
Aruwajoye OO; Aswath PB; Kim HKW
J Orthop Res; 2017 Jul; 35(7):1453-1460. PubMed ID: 27564450
[TBL] [Abstract][Full Text] [Related]
2. Local administration of bone morphogenetic protein-2 and bisphosphonate during non-weight-bearing treatment of ischemic osteonecrosis of the femoral head: an experimental investigation in immature pigs.
Kim HK; Aruwajoye O; Du J; Kamiya N
J Bone Joint Surg Am; 2014 Sep; 96(18):1515-24. PubMed ID: 25232075
[TBL] [Abstract][Full Text] [Related]
3. Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head: a combined therapy that stimulates bone formation and decreases femoral head deformity.
Vandermeer JS; Kamiya N; Aya-ay J; Garces A; Browne R; Kim HK
J Bone Joint Surg Am; 2011 May; 93(10):905-13. PubMed ID: 21593365
[TBL] [Abstract][Full Text] [Related]
4. Microcrack density and nanomechanical properties in the subchondral region of the immature piglet femoral head following ischemic osteonecrosis.
Aruwajoye OO; Patel MK; Allen MR; Burr DB; Aswath PB; Kim HK
Bone; 2013 Feb; 52(2):632-9. PubMed ID: 22889721
[TBL] [Abstract][Full Text] [Related]
5. Commentary on an article by Jacob S. Vandermeer et al.: "Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head. A combined therapy that stimulates bone formation and decreases femoral head deformity".
Baumgarten KM
J Bone Joint Surg Am; 2011 May; 93(10):e57. PubMed ID: 21593363
[No Abstract] [Full Text] [Related]
6. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
Little DG; Kim HK
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
[TBL] [Abstract][Full Text] [Related]
7. Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head.
Aya-ay J; Athavale S; Morgan-Bagley S; Bian H; Bauss F; Kim HK
J Bone Miner Res; 2007 Jan; 22(1):93-100. PubMed ID: 17166092
[TBL] [Abstract][Full Text] [Related]
8. Drilling Combined with Adipose-derived Stem Cells and Bone Morphogenetic Protein-2 to Treat Femoral Head Epiphyseal Necrosis in Juvenile Rabbits.
Wang ZL; He RZ; Tu B; He JS; Cao X; Xia HS; Ba HL; Wu S; Peng C; Xiong K
Curr Med Sci; 2018 Apr; 38(2):277-288. PubMed ID: 30074186
[TBL] [Abstract][Full Text] [Related]
9. Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs.
Cheng TL; Murphy CM; Cantrill LC; Mikulec K; Carpenter C; Schindeler A; Little DG
Int Orthop; 2014 Jul; 38(7):1527-33. PubMed ID: 24389948
[TBL] [Abstract][Full Text] [Related]
10. Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs.
Kim HK; Randall TS; Bian H; Jenkins J; Garces A; Bauss F
J Bone Joint Surg Am; 2005 Mar; 87(3):550-7. PubMed ID: 15741621
[TBL] [Abstract][Full Text] [Related]
11. Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease.
Young ML; Little DG; Kim HK
Clin Orthop Relat Res; 2012 Sep; 470(9):2462-75. PubMed ID: 22270467
[TBL] [Abstract][Full Text] [Related]
12. Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.
Johannesen J; Briody J; McQuade M; Little DG; Cowell CT; Munns CF
Bone; 2009 Nov; 45(5):898-902. PubMed ID: 19446052
[TBL] [Abstract][Full Text] [Related]
13. Intraosseous Delivery of Bone Morphogenic Protein-2 Using a Self-Assembling Peptide Hydrogel.
Phipps MC; Monte F; Mehta M; Kim HK
Biomacromolecules; 2016 Jul; 17(7):2329-36. PubMed ID: 27285121
[TBL] [Abstract][Full Text] [Related]
14. [Biphosphonate in the treatment of avascular necrosis of the femoral head].
Shabtai L; Drexler M; Blummberg N
Harefuah; 2012 Apr; 151(4):242-5, 252. PubMed ID: 22616155
[TBL] [Abstract][Full Text] [Related]
15. Bone apatite composition of necrotic trabecular bone in the femoral head of immature piglets.
Aruwajoye OO; Kim HK; Aswath PB
Calcif Tissue Int; 2015 Apr; 96(4):324-34. PubMed ID: 25660159
[TBL] [Abstract][Full Text] [Related]
16. Ischemic femoral head osteonecrosis in a piglet model causes three dimensional decrease in acetabular coverage.
Upasani VV; Jeffords ME; Farnsworth CL; Padilla D; Lopreiato N; Aruwajoye OO; Kim HKW
J Orthop Res; 2018 Apr; 36(4):1173-1177. PubMed ID: 28914956
[TBL] [Abstract][Full Text] [Related]
17. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
Kim HK; Morgan-Bagley S; Kostenuik P
J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.
Little DG; Peat RA; Mcevoy A; Williams PR; Smith EJ; Baldock PA
J Bone Miner Res; 2003 Nov; 18(11):2016-22. PubMed ID: 14606515
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Transphyseal Neck-Head Tunneling and Multiple Epiphyseal Drilling on Femoral Head Healing Following Ischemic Osteonecrosis: An Experimental Investigation in Immature Pigs.
Aruwajoye OO; Monte F; Kim A; Kim HKW
J Pediatr Orthop; 2020 Apr; 40(4):168-175. PubMed ID: 32132446
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between the bone mass and the expressions of vascular endothelial growth factor, basic fibroblast growth factor, and bone morphogenetic protein 2 mRNA in avascular necrosis of femoral head].
Wang W; Li S; Niu D; Liu F; Sun J; Zhang Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Aug; 25(8):984-91. PubMed ID: 21923031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
